Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 4
1988 1
1989 2
1990 1
1991 2
1992 3
1993 1
1994 7
1995 3
1996 9
1997 5
1998 3
1999 1
2000 1
2002 6
2003 3
2004 3
2005 4
2006 2
2007 1
2008 4
2009 2
2010 2
2011 6
2012 1
2013 4
2014 3
2015 6
2016 9
2017 9
2018 5
2019 4
2020 1
2021 1
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Autoantibodies in systemic lupus erythematosus.
Cabral AR, Alarcón-Segovia D. Cabral AR, et al. Curr Opin Rheumatol. 1997 Sep;9(5):387-92. doi: 10.1097/00002281-199709000-00003. Curr Opin Rheumatol. 1997. PMID: 9309193 Review.
Autoantibodies in systemic lupus erythematosus.
Cabral AR, Alarcón-Segovia D. Cabral AR, et al. Curr Opin Rheumatol. 1998 Sep;10(5):409-16. doi: 10.1097/00002281-199809000-00003. Curr Opin Rheumatol. 1998. PMID: 9746855 Review.
The antiphospholipid/cofactor syndromes.
Alarcón-Segovia D, Cabral AR. Alarcón-Segovia D, et al. Among authors: cabral ar. J Rheumatol. 1996 Aug;23(8):1319-22. J Rheumatol. 1996. PMID: 8856607 No abstract available.
Anti-beta 2-glycoprotein-I antibodies in scFv format.
Cabiedes J, Cabral AR. Cabiedes J, et al. Among authors: cabral ar. Autoimmun Rev. 2005 Jun;4(5):289-95. doi: 10.1016/j.autrev.2004.12.006. Epub 2005 Jan 27. Autoimmun Rev. 2005. PMID: 15990076 Review.
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
Ferdowsi N, Huq M, Stevens W, Hudson M, Wang M, Tay T, Burchell JL, Mancuso S, Rabusa C, Sundararajan V, Prior D, Proudman SM, Baron M, Nikpour M; Scleroderma Clinical Trials Consortium Damage Index Working Group, The Australian Scleroderma Interest Group, Canadian Scleroderma Research Group; Scleroderma Clinical Trials Consortium Damage Index Working Group, TheAustralian Scleroderma Interest Group, Canadian Scleroderma Research Group. Ferdowsi N, et al. Ann Rheum Dis. 2019 Jun;78(6):807-816. doi: 10.1136/annrheumdis-2018-214764. Epub 2019 Mar 30. Ann Rheum Dis. 2019. PMID: 30928903
Churg-Strauss syndrome and hemorrhagic vasculitis.
Marques RM, Cabral AR, Monteiro A, Henriques P. Marques RM, et al. Among authors: cabral ar. Dermatol Reports. 2011 Dec 2;3(3):e49. doi: 10.4081/dr.2011.e49. eCollection 2011 Oct 5. Dermatol Reports. 2011. PMID: 25386301 Free PMC article.
114 results